Phosphorylase
Inhibitory Selectivity
Phosphorylase Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S2717 |
CP-91149CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose. |
C, experimental design illustrating the time points in which PYGL inhibitor CP-91149 (GPi) and 2DG were added to the groups depicted in D to J. D, representative images of cell invasion through the Boyden chamber from control, 2DG and recovery GBM1 treated with GPi or DMSO. E to G, comparison of the invasive capacity of EV or shG6PC in the presence or absence of GPi. |
|
| S0031 |
IngliforibIngliforib (CP 368296) is a glycogen phosphorylase (GP) inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity. |
||
| S6510 |
Iso-H7 dihydrochlorideIso-H7 dihydrochloride is an inhibitor of phosphokinase C. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S2717 |
CP-91149CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose. |
C, experimental design illustrating the time points in which PYGL inhibitor CP-91149 (GPi) and 2DG were added to the groups depicted in D to J. D, representative images of cell invasion through the Boyden chamber from control, 2DG and recovery GBM1 treated with GPi or DMSO. E to G, comparison of the invasive capacity of EV or shG6PC in the presence or absence of GPi. |
|
| S0031 |
IngliforibIngliforib (CP 368296) is a glycogen phosphorylase (GP) inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity. |
||
| S6510 |
Iso-H7 dihydrochlorideIso-H7 dihydrochloride is an inhibitor of phosphokinase C. |
